Clinical trials
Neoplasia clinical trials
Below are recruiting neoplasia clinical trials, each written for real people, not researchers. We’re tracking 113 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03855592Recruiting
Cancer patients with blood clots: thrombosis and cancer registry
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
Alcoy, AlicanteAges 18 years+ - NCT03713229Enrolling by invitation
Seville study of people with HIV at risk for anal cancer
This study follows people living with HIV who may be at higher risk for anal cancer. It aims to better understand risk and outcomes, which could help guide future screening or prevention.
SevilleAges 18 years+ - NCT03463668Recruiting
Testing a specific duodenal stent for duodenal narrowing
This trial is looking back at people with symptoms from narrowing of the duodenum (the first part of the small intestine) who had a specific type of stent placed between 2010 and 2017. It may help doctors understand how well these “uncovered” duodenal stents work over time, and who benefits.
Marseille, Bouches Du RhoneAges 18 years+ - NCT03039309Recruiting
Testing endoscopic removal for early stomach or gut growth
This study looks at endoscopic submucosal dissection, a procedure to remove early growths in the stomach or other parts of the GI tract, using the UK approach. You may benefit by having your treatment guided within a research study and closer follow-up.
PortsmouthAges 18 years+ - NCT03183115Recruiting
Prevent return of esophagus pre-cancer after endoscopy
This trial looks at a prevention treatment to stop esophagus abnormal growth (pre-cancer or very early cancer) from coming back after successful endoscopic submucosal dissection. It focuses on people whose esophagus lining shows a “speckled” pattern on a special iodine test, which may mean higher risk of recurrence.
Kaohsiung CityAges 20–90 - NCT03048266Recruiting
Testing genes and blood chemistry in MEN1 pancreatic tumors
This study looks at blood chemistry (metabolomics) and genetic information in people who have MEN1, especially if they are being evaluated for pancreatic neuroendocrine tumors. It may help doctors better diagnose these tumors by finding patterns in test results.
Houston, TexasAges Any age - NCT07740122Recruiting
Stool photo analysis for colorectal cancer screening
This study tests whether photos of your stool can help predict your risk of colorectal cancer or precancerous growths. It uses a smartphone app to analyze stool images alongside your routine stool test (FIT) results.
Santiago, Santiago MetropolitanAges 18 years+ - NCT02925234RecruitingPhase 2
Basket trial of reused cancer drugs matched to tumor markers
This trial tests cancer drugs that are already approved for other cancers, chosen based on specific changes found in your tumor. It may help people whose cancer is growing despite standard treatment (or who no longer have standard options).
AlkmaarAges 18 years+ - NCT01882205Recruiting
Testing new camera methods to find precancer in ulcerative colitis
This study compares different special camera techniques during colonoscopy to see which best finds early abnormal (pre-cancer) changes in people with long-term ulcerative colitis. It may help doctors improve how they screen and monitor your colon over time.
LeuvenAges 18 years+ - NCT01577251Recruiting
Cancer patients on radiation can join a registry
This study builds a registry and blood/tissue sample collection for people who have cancer or a non-cancer growth (benign tumor) and are receiving radiation. It helps researchers learn from real-world treatment and biology, which may improve future care.
Moorestown, New JerseyAges 18 years+ - NCT02049658Recruiting
Using a sniff dog to check for suspected tumors
This trial studies whether a trained sniff dog can help detect or rule out tumors in people with suspicious spots and in healthy people without tumors. It may be useful as a quick screening tool alongside regular medical tests.
Changsha, HunanAges 1 year+ - NCT00590239Recruiting
Study for early changes in Barrett’s esophagus
This study focuses on people with Barrett’s esophagus who are coming in for an endoscopy check or for treatment of early surface changes. The goal is to better understand these early warning areas and how to manage them safely.
Kansas City, MissouriAges 18 years+ - NCT07786818Recruiting
Colorectal cancer screening marker study
This study looks for markers in stool and saliva that might indicate the presence of precancerous growths in the colon. If you are scheduled for a colonoscopy, you may be able to participate by providing samples beforehand.
Bothell, WashingtonAges 18 years+ - NCT07461818Recruiting
Quick treatment for cervical pre-cancer
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
San Salvador, San Salvador DepartmentAges 30–49 - NCT07623902Recruiting
Tongue test to improve colorectal cancer screening
This study is testing a new, non-invasive tongue test called Gixam. The goal is to see if the test can help detect colorectal cancer or pre-cancerous growths in people whose standard stool tests (FIT) came back negative, potentially improving screening accuracy.
Mobile, AlabamaAges 45–84 - NCT07833852Enrolling by invitation
Long-term protection study for bivalent HPV vaccine
This study follows up with people who received the bivalent HPV vaccine to see how long their protection lasts and whether any breakthrough infections occur. It involves extra blood tests or follow-up visits over several years.
Mianyang, SichuanAges 12–34 - NCT07480902Recruiting
Comparing two tests for cervical cancer detection
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Mexico City, Mexico CityAges 18–85
Hear when a new Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasia?
- Yes. Clin2 currently lists 113 recruiting neoplasia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.